Tyr-dTrp-Gly-Phe-Met-NH2 is a unique synthetic Met5-enkephalin peptide analog that at concentrations of 1–100 μg/ml incubation medium acts directly on the pituitary of rats in vitro to release GH specifically but not LH, FSH, TSH, PRL, or ACTH. Structure-activity studies of this pentapeptide emphasize the prime importance of an aromatic amino acid residue at the 2 position for in vitro GH-releasing activity. Both Tyr-dTrp-Gly-Phe-Met-NH2, and Tyr-dPhe-Gly-Phe-Met-NH2 released GH in vitro, while large concentrations of seven enkephalin analogs, which did not have an aromatic amino acid residue in the 2 position, had essentially no GH-releasing activity. In addition, the importance of a dTrp or dPhe rather than an lTrp or lPhe residue in the 2 position was apparent, since neither Tyr-lTrp-Gly-Phe-Met-NH2 nor Tyr-lPhe-Gly-Phe- Met-NH2 were active. Although the GH-releasing activity of the C-terminal nonamidated Tyr-dTrp-Gly-Phe-Met peptide was not determined, the nonamidated Tyr-dPhe-Gly-Phe-Met peptide was ...
No takes yet. Share an insight, caveat, or question.
Bowers et al. (1980) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: